Verastem raises ~$97.8M in underwritten offering of common stock and pre-funded warrants

Verastem, Inc.

Offering includes 7,181,409 shares at $9.75, 1,538,591 pre-funded warrants at $9.749, and underwriters' option for 1,308,000 shares exercised in full.
Pre-funded warrants have $0.001 exercise price and 9.99% beneficial ownership limitation (waivable to 19.99%).
Closing expected June 21, 2023; proceeds for general corporate purposes (not specified).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.